Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts.

Angenendt L, Röllig C, Montesinos P, Martínez-Cuadrón D, Barragan E, García R, Botella C, Martínez P, Ravandi F, Kadia T, Kantarjian HM, Cortes J, Juliusson G, Lazarevic V, Höglund M, Lehmann S, Recher C, Pigneux A, Bertoli S, Dumas PY, Dombret H, Preudhomme C, Micol JB, Terré C, Ráčil Z, Novák J, Žák P, Wei AH, Tiong IS, Wall M, Estey E, Shaw C, Exeler R, Wagenführ L, Stölzel F, Thiede C, Stelljes M, Lenz G, Mikesch JH, Serve H, Ehninger G, Berdel WE, Kramer M, Krug U, Schliemann C.

J Clin Oncol. 2019 Oct 10;37(29):2632-2642. doi: 10.1200/JCO.19.00416. Epub 2019 Aug 20.

PMID:
31430225
2.

Development, Implementation and Assessment of Molecular Diagnostics by Next Generation Sequencing in Personalized Treatment of Cancer: Experience of a Public Reference Healthcare Hospital.

Simarro J, Murria R, Pérez-Simó G, Llop M, Mancheño N, Ramos D, Juan I, Barragán E, Laiz B, Cases E, Ansótegui E, Gómez-Codina J, Aparicio J, Salvador C, Juan Ó, Palanca S.

Cancers (Basel). 2019 Aug 16;11(8). pii: E1196. doi: 10.3390/cancers11081196.

3.

IDH1-mutated relapsed or refractory AML: current challenges and future prospects.

Megías-Vericat JE, Ballesta-López O, Barragán E, Montesinos P.

Blood Lymphat Cancer. 2019 Jun 27;9:19-32. doi: 10.2147/BLCTT.S177913. eCollection 2019. Review.

4.

Incidence and outcome of invasive fungal disease after front-line intensive chemotherapy in patients with acute myeloid leukemia: impact of antifungal prophylaxis.

Rodríguez-Veiga R, Montesinos P, Boluda B, Lorenzo I, Martínez-Cuadrón D, Salavert M, Pemán J, Calvillo P, Cano I, Acuña E, Villalba A, Piñana JL, Sanz J, Solves P, Senent L, Vicente A, Sempere A, Cervera J, Barragán E, Jarque I, Torres A, Sanz MA, Sanz GF.

Ann Hematol. 2019 Sep;98(9):2081-2088. doi: 10.1007/s00277-019-03744-5. Epub 2019 Jun 25.

PMID:
31240471
5.

Awareness of obstetric warning signs in Ecuador: a cross-sectional study.

Bustamante G, Mantilla B, Cabrera-Barona P, Barragán E, Soria S, Quizhpe E, Jiménez Aguilar AP, Hinojosa Trujillo MH, Wang E, Grunauer M.

Public Health. 2019 Jul;172:52-60. doi: 10.1016/j.puhe.2019.04.013. Epub 2019 Jun 12.

PMID:
31202092
6.

RNA Sequencing Analysis for the Identification of a PCM1/PDGFRB Fusion Gene Responsive to Imatinib.

Such E, Liquori A, Mora E, Marco-Ayala J, Avetisyan G, Regadera A, Ibañez F, Panadero J, Senent L, Llop M, Díaz A, Vicente A, Luna I, Ibáñez M, Barragán E, Sanz MA, Sanz G, Communidad Valenciana, Cervera J.

Acta Haematol. 2019;142(2):92-97. doi: 10.1159/000497348. Epub 2019 May 14.

PMID:
31085913
7.

Illuminating Women's Hidden Contribution to Historical Theoretical Population Genetics.

Dung SK, López A, Barragan EL, Reyes RJ, Thu R, Castellanos E, Catalan F, Huerta-Sánchez E, Rohlfs RV.

Genetics. 2019 Feb;211(2):363-366. doi: 10.1534/genetics.118.301277.

8.

Clinical Utility of a Next-Generation Sequencing Panel for Acute Myeloid Leukemia Diagnostics.

Alonso CM, Llop M, Sargas C, Pedrola L, Panadero J, Hervás D, Cervera J, Such E, Ibáñez M, Ayala R, Martínez-López J, Onecha E, de Juan I, Palanca S, Martínez-Cuadrón D, Rodríguez-Veiga R, Boluda B, Montesinos P, Sanz G, Sanz MA, Barragán E.

J Mol Diagn. 2019 Mar;21(2):228-240. doi: 10.1016/j.jmoldx.2018.09.009. Epub 2018 Dec 19.

PMID:
30576870
9.

Focal Adhesion Genes Refine the Intermediate-Risk Cytogenetic Classification of Acute Myeloid Leukemia.

Pallarès V, Hoyos M, Chillón MC, Barragán E, Prieto Conde MI, Llop M, Falgàs A, Céspedes MV, Montesinos P, Nomdedeu JF, Brunet S, Sanz MÁ, González-Díaz M, Sierra J, Mangues R, Casanova I.

Cancers (Basel). 2018 Nov 13;10(11). pii: E436. doi: 10.3390/cancers10110436.

10.

A reproducible strategy for analysis of minimal residual disease measured by Standardized multiparametric flow cytometry in b acute lymphoblastic leukemia.

Sarmiento Palao H, Tarín F, Martirena F, Barragán E, Such E, Sempere A, Tasso M, Manresa P, López F.

Cytometry B Clin Cytom. 2019 Jan;96(1):12-15. doi: 10.1002/cyto.b.21720. Epub 2018 Oct 24. No abstract available.

PMID:
30353651
11.

The modular network structure of the mutational landscape of Acute Myeloid Leukemia.

Ibáñez M, Carbonell-Caballero J, Such E, García-Alonso L, Liquori A, López-Pavía M, Llop M, Alonso C, Barragán E, Gómez-Seguí I, Neef A, Hervás D, Montesinos P, Sanz G, Sanz MA, Dopazo J, Cervera J.

PLoS One. 2018 Oct 10;13(10):e0202926. doi: 10.1371/journal.pone.0202926. eCollection 2018.

12.

A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia.

Onecha E, Linares M, Rapado I, Ruiz-Heredia Y, Martinez-Sanchez P, Cedena T, Pratcorona M, Oteyza JP, Herrera P, Barragan E, Montesinos P, Vela JAG, Magro E, Anguita E, Figuera A, Riaza R, Martinez-Barranco P, Sanchez-Vega B, Nomdedeu J, Gallardo M, Martinez-Lopez J, Ayala R.

Haematologica. 2019 Feb;104(2):288-296. doi: 10.3324/haematol.2018.194712. Epub 2018 Aug 9.

13.

Missing: Where Are the Migrants in Pandemic Influenza Preparedness Plans?

Wickramage K, Gostin LO, Friedman E, Prakongsai P, Suphanchaimat R, Hui C, Duigan P, Barragan E, Harper DR.

Health Hum Rights. 2018 Jun;20(1):251-258. No abstract available.

14.

Psychedelics Promote Structural and Functional Neural Plasticity.

Ly C, Greb AC, Cameron LP, Wong JM, Barragan EV, Wilson PC, Burbach KF, Soltanzadeh Zarandi S, Sood A, Paddy MR, Duim WC, Dennis MY, McAllister AK, Ori-McKenney KM, Gray JA, Olson DE.

Cell Rep. 2018 Jun 12;23(11):3170-3182. doi: 10.1016/j.celrep.2018.05.022.

15.

Metaplasticity contributes to memory formation in the hippocampus.

Crestani AP, Krueger JN, Barragan EV, Nakazawa Y, Nemes SE, Quillfeldt JA, Gray JA, Wiltgen BJ.

Neuropsychopharmacology. 2019 Jan;44(2):408-414. doi: 10.1038/s41386-018-0096-7. Epub 2018 May 16.

PMID:
29849054
16.

A Rare Case of Pure Erythroid Sarcoma in a Pediatric Patient: Case Report and Literature Review.

Manresa P, Tarín F, Niveiro M, Tasso M, Alda O, López F, Sarmiento H, Verdú JJ, De Paz F, López S, Del Cañizo M, Such E, Barragán E, Martirena F.

Children (Basel). 2017 Dec 20;4(12). pii: E113. doi: 10.3390/children4120113.

17.

NEDD9, an independent good prognostic factor in intermediate-risk acute myeloid leukemia patients.

Pallarès V, Hoyos M, Chillón MC, Barragán E, Conde MIP, Llop M, Céspedes MV, Nomdedeu JF, Brunet S, Sanz MÁ, González-Díaz M, Sierra J, Casanova I, Mangues R.

Oncotarget. 2017 Jun 16;8(44):76003-76014. doi: 10.18632/oncotarget.18537. eCollection 2017 Sep 29.

18.

Comparative genomic analysis of PML and RARA breakpoints in paired diagnosis/relapse samples of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.

Iaccarino L, Ottone T, Hasan SK, Divona M, Cicconi L, Lavorgna S, Alfonso V, Basso G, Barragán E, Bocchia M, Rego EM, Grimwade D, Voso MT, Lo-Coco F.

Leuk Lymphoma. 2018 May;59(5):1268-1270. doi: 10.1080/10428194.2017.1369067. Epub 2017 Aug 24. No abstract available.

PMID:
28838264
19.

Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.

Forero-Castro M, Robledo C, Benito R, Bodega-Mayor I, Rapado I, Hernández-Sánchez M, Abáigar M, Maria Hernández-Sánchez J, Quijada-Álamo M, María Sánchez-Pina J, Sala-Valdés M, Araujo-Silva F, Kohlmann A, Luis Fuster J, Arefi M, de Las Heras N, Riesco S, Rodríguez JN, Hermosín L, Ribera J, Camos Guijosa M, Ramírez M, de Heredia Rubio CD, Barragán E, Martínez J, Ribera JM, Fernández-Ruiz E, Hernández-Rivas JM.

Br J Cancer. 2017 Jul 11;117(2):256-265. doi: 10.1038/bjc.2017.152. Epub 2017 May 30.

20.

Wilms Tumor 1 gene expression levels improve risk stratification in AML patients. Results of a multicentre study within the Spanish Group for Molecular Biology in Haematology.

Martínez-Laperche C, Kwon M, Franco-Villegas AC, Chillón MC, Castro N, Anguita E, Dolz S, Rodríguez-Medina C, Hermosín L, Bellón JM, Prieto-Conde MI, Barragán E, Gómez-Casares M, Ayala R, Martínez-López J, González-Díaz M, Díez-Martin JL, Buño I; Cooperative Group for Molecular Biology in Haematology (GBMH).

Br J Haematol. 2018 May;181(4):542-546. doi: 10.1111/bjh.14635. Epub 2017 Apr 3. No abstract available.

PMID:
28369773
21.

π-Conjugated Triazenes: Intermediates That Undergo Oxidation and Substitution Reactions.

Barragan E, Bugarin A.

J Org Chem. 2017 Feb 3;82(3):1499-1506. doi: 10.1021/acs.joc.6b02705. Epub 2017 Jan 25.

PMID:
28085277
22.

Activity-Dependent Palmitoylation Controls SynDIG1 Stability, Localization, and Function.

Kaur I, Yarov-Yarovoy V, Kirk LM, Plambeck KE, Barragan EV, Ontiveros ES, Díaz E.

J Neurosci. 2016 Jul 20;36(29):7562-8. doi: 10.1523/JNEUROSCI.4859-14.2016.

23.

Bone marrow fibrosis in myelodysplastic syndromes: a prospective evaluation including mutational analysis.

Ramos F, Robledo C, Izquierdo-García FM, Suárez-Vilela D, Benito R, Fuertes M, Insunza A, Barragán E, Del Rey M, García-Ruiz de Morales JM, Tormo M, Salido E, Zamora L, Pedro C, Sánchez-Del-Real J, Díez-Campelo M, Del Cañizo C, Sanz GF, Hernández-Rivas JM; Spanish Group for Myelodysplastic Syndromes (GESMD).

Oncotarget. 2016 May 24;7(21):30492-503. doi: 10.18632/oncotarget.9026.

24.

The Mutational Landscape of Acute Promyelocytic Leukemia Reveals an Interacting Network of Co-Occurrences and Recurrent Mutations.

Ibáñez M, Carbonell-Caballero J, García-Alonso L, Such E, Jiménez-Almazán J, Vidal E, Barragán E, López-Pavía M, LLop M, Martín I, Gómez-Seguí I, Montesinos P, Sanz MA, Dopazo J, Cervera J.

PLoS One. 2016 Feb 17;11(2):e0148346. doi: 10.1371/journal.pone.0148346. eCollection 2016.

25.

Model systems for studying cellular mechanisms of SCN1A-related epilepsy.

Schutte SS, Schutte RJ, Barragan EV, O'Dowd DK.

J Neurophysiol. 2016 Apr;115(4):1755-66. doi: 10.1152/jn.00824.2015. Epub 2016 Feb 3. Review.

26.

Immunohistochemical, genetic and epigenetic profiles of hereditary and triple negative breast cancers. Relevance in personalized medicine.

Murria R, Palanca S, de Juan I, Alenda C, Egoavil C, Seguí FJ, García-Casado Z, Juan MJ, Sánchez AB, Segura Á, Santaballa A, Chirivella I, Llop M, Pérez G, Barragán E, Salas D, Bolufer P.

Am J Cancer Res. 2015 Jun 15;5(7):2330-43. eCollection 2015.

27.

BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.

de Juan I, Palanca S, Domenech A, Feliubadaló L, Segura Á, Osorio A, Chirivella I, de la Hoya M, Sánchez AB, Infante M, Tena I, Díez O, Garcia-Casado Z, Vega A, Teulé À, Barroso A, Pérez P, Durán M, Carrasco E, Juan-Fita MJ, Murria R, Llop M, Barragan E, Izquierdo Á, Benítez J, Caldés T, Salas D, Bolufer P.

Fam Cancer. 2015 Dec;14(4):505-13. doi: 10.1007/s10689-015-9814-z.

PMID:
26026974
28.

Study of the S427G polymorphism and of MYBL2 variants in patients with acute myeloid leukemia.

Dolz S, García P, Llop M, Fuster Ó, Luna I, Ibáñez M, Gómez I, López M, Such E, Cervera J, Sanz MA, De Juan I, Palanca S, Murria R, Bolufer P, Barragán E.

Leuk Lymphoma. 2016 Feb;57(2):429-435. doi: 10.3109/10428194.2015.1049167. Epub 2015 Jun 19.

PMID:
26014440
29.

Quantifying insufficient coping behavior under chronic stress: a cross-cultural study of 1,303 students from Italy, Spain and Argentina.

Delfino JP, Barragán E, Botella C, Braun S, Bridler R, Camussi E, Chafrat V, Lott P, Mohr C, Moragrega I, Papagno C, Sanchez S, Seifritz E, Soler C, Stassen HH.

Psychopathology. 2015;48(4):230-9. doi: 10.1159/000381400. Epub 2015 May 7.

30.

Trends in research involving human beings in Brazil.

Silva RE, Novaes MR, Pastor EM, Barragan E, Amato AA.

Rev Panam Salud Publica. 2015 Feb;37(2):118-24.

PMID:
25915017
31.

The removal of a gastric balloon: a case study.

Barragan E, Kihara E, Lara L.

Gastroenterol Nurs. 2015 Mar-Apr;38(2):122-4. doi: 10.1097/SGA.0000000000000100. No abstract available.

PMID:
25831250
32.

CIP2A high expression is a poor prognostic factor in normal karyotype acute myeloid leukemia.

Barragán E, Chillón MC, Castelló-Cros R, Marcotegui N, Prieto MI, Hoyos M, Pippa R, Llop M, Etxabe A, Cervera J, Rodríguez G, Buño I, Rifón J, Sierra J, González M, Calasanz MJ, Sanz MA, Odero MD.

Haematologica. 2015 May;100(5):e183-5. doi: 10.3324/haematol.2014.118117. Epub 2015 Jan 30. No abstract available.

33.

Methylation of tumor suppressor genes is related with copy number aberrations in breast cancer.

Murria R, Palanca S, de Juan I, Egoavil C, Alenda C, García-Casado Z, Juan MJ, Sánchez AB, Santaballa A, Chirivella I, Segura Á, Hervás D, Llop M, Barragán E, Bolufer P.

Am J Cancer Res. 2014 Dec 15;5(1):375-85. eCollection 2015.

34.

Single-nucleotide polymorphism array-based karyotyping of acute promyelocytic leukemia.

Gómez-Seguí I, Sánchez-Izquierdo D, Barragán E, Such E, Luna I, López-Pavía M, Ibáñez M, Villamón E, Alonso C, Martín I, Llop M, Dolz S, Fuster O, Montesinos P, Cañigral C, Boluda B, Salazar C, Cervera J, Sanz MA.

PLoS One. 2014 Jun 24;9(6):e100245. doi: 10.1371/journal.pone.0100245. eCollection 2014.

35.

Knock-in model of Dravet syndrome reveals a constitutive and conditional reduction in sodium current.

Schutte RJ, Schutte SS, Algara J, Barragan EV, Gilligan J, Staber C, Savva YA, Smith MA, Reenan R, O'Dowd DK.

J Neurophysiol. 2014 Aug 15;112(4):903-12. doi: 10.1152/jn.00135.2014. Epub 2014 May 7.

36.

α-Thalassemia does not seem to influence erythrocyte deformability in sickle cell trait carriers.

Vayá A, Collado S, Alis R, Vera B, Romagnoli M, Barragán E.

Hemoglobin. 2014;38(3):165-8. doi: 10.3109/03630269.2014.888353. Epub 2014 Mar 7.

PMID:
24601859
37.

Efficacy and Safety of Omega-3/6 Fatty Acids, Methylphenidate, and a Combined Treatment in Children With ADHD.

Barragán E, Breuer D, Döpfner M.

J Atten Disord. 2017 Mar;21(5):433-441. doi: 10.1177/1087054713518239. Epub 2016 Jul 28.

PMID:
24464327
38.

WT1 isoform expression pattern in acute myeloid leukemia.

Luna I, Such E, Cervera J, Barragán E, Ibañez M, Gómez-Seguí I, López-Pavía M, Llop M, Fuster O, Dolz S, Oltra S, Alonso C, Vera B, Lorenzo I, Martínez-Cuadrón D, Montesinos P, Senent ML, Moscardó F, Bolufer P, Sanz MA.

Leuk Res. 2013 Dec;37(12):1744-9. doi: 10.1016/j.leukres.2013.10.009. Epub 2013 Oct 22.

PMID:
24211094
39.

Adverse prognostic value of MYBL2 overexpression and association with microRNA-30 family in acute myeloid leukemia patients.

Fuster O, Llop M, Dolz S, García P, Such E, Ibáñez M, Luna I, Gómez I, López M, Cervera J, Montesinos P, Moscardó F, Cordón L, Solves P, de Juan I, Palanca S, Bolufer P, Sanz MÁ, Barragán E.

Leuk Res. 2013 Dec;37(12):1690-6. doi: 10.1016/j.leukres.2013.09.015. Epub 2013 Sep 21.

PMID:
24199710
40.

Single nucleotide polymorphism array karyotyping: a diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing.

Arenillas L, Mallo M, Ramos F, Guinta K, Barragán E, Lumbreras E, Larráyoz MJ, De Paz R, Tormo M, Abáigar M, Pedro C, Cervera J, Such E, José Calasanz M, Díez-Campelo M, Sanz GF, Hernández JM, Luño E, Saumell S, Maciejewski J, Florensa L, Solé F.

Genes Chromosomes Cancer. 2013 Dec;52(12):1167-77. doi: 10.1002/gcc.22112. Epub 2013 Oct 7.

PMID:
24123380
41.

Novel real-time polymerase chain reaction assay for simultaneous detection of recurrent fusion genes in acute myeloid leukemia.

Dolz S, Barragán E, Fuster Ó, Llop M, Cervera J, Such E, De Juan I, Palanca S, Murria R, Bolufer P, Luna I, Gómez I, López M, Ibáñez M, Sanz MA.

J Mol Diagn. 2013 Sep;15(5):678-86. doi: 10.1016/j.jmoldx.2013.04.003. Epub 2013 Jun 25.

PMID:
23806810
42.

Erythrocyte deformability and aggregation in homozygous sickle cell disease.

Vayá A, Collado S, Dasí MA, Pérez ML, Hernandez JL, Barragán E.

Clin Hemorheol Microcirc. 2014;58(4):497-505. doi: 10.3233/CH-131717.

PMID:
23603322
43.

The deletion of exons 3-5 of BRCA1 is the first founder rearrangement identified in breast and/or ovarian cancer Spanish families.

Palanca S, de Juan I, Perez-Simó G, Barragán E, Chirivella I, Martínez E, Fuster O, Bolufer P.

Fam Cancer. 2013 Mar;12(1):119-23. doi: 10.1007/s10689-012-9579-6.

PMID:
23117300
44.

Analysis of SNP rs16754 of WT1 gene in a series of de novo acute myeloid leukemia patients.

Luna I, Such E, Cervera J, Barragán E, Jiménez-Velasco A, Dolz S, Ibáñez M, Gómez-Seguí I, López-Pavía M, Llop M, Fuster Ó, Oltra S, Moscardó F, Martínez-Cuadrón D, Senent ML, Gascón A, Montesinos P, Martín G, Bolufer P, Sanz MA.

Ann Hematol. 2012 Dec;91(12):1845-53. doi: 10.1007/s00277-012-1596-x. Epub 2012 Oct 16.

PMID:
23070125
45.

Ethics education in research involving human beings in undergraduate medicine curriculum in Brazil.

Novaes MR, Guilhem D, Barragan E, Mennin S.

Dev World Bioeth. 2013 Dec;13(3):163-8. doi: 10.1111/j.1471-8847.2012.00336.x. Epub 2012 Sep 20.

PMID:
22994866
46.

Rapid screening of ASXL1, IDH1, IDH2, and c-CBL mutations in de novo acute myeloid leukemia by high-resolution melting.

Ibáñez M, Such E, Cervera J, Luna I, Gómez-Seguí I, López-Pavía M, Dolz S, Barragán E, Fuster O, Llop M, Rodríguez-Veiga R, Avaria A, Oltra S, Senent ML, Moscardó F, Montesinos P, Martínez-Cuadrón D, Martín G, Sanz MA.

J Mol Diagn. 2012 Nov;14(6):594-601. doi: 10.1016/j.jmoldx.2012.06.006. Epub 2012 Aug 25. Erratum in: J Mol Diagn. 2013 Mar;15(2):280.

PMID:
22929312
47.

Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in peripheral blood adversely affects survival.

Santamaría C, Ramos F, Puig N, Barragán E, de Paz R, Pedro C, Insunza A, Tormo M, Del Cañizo C, Diez-Campelo M, Xicoy B, Salido E, Sánchez del Real J, Hernández M, Chillón C, Sanz GF, García-Sanz R, San Miguel JF, González M.

Ann Hematol. 2012 Dec;91(12):1887-95. doi: 10.1007/s00277-012-1538-7. Epub 2012 Aug 9.

PMID:
22875062
48.

Comparative molecular analysis of therapy-related and de novo acute promyelocytic leukemia.

Ottone T, Cicconi L, Hasan SK, Lavorgna S, Divona M, Voso MT, Montefusco E, Melillo L, Barragán E, Platzbecker U, Giannì L, Hubmann M, Pagoni M, Amadori S, Lo-Coco F.

Leuk Res. 2012 Apr;36(4):474-8. doi: 10.1016/j.leukres.2011.10.015. Epub 2011 Nov 8.

PMID:
22071137
49.

Prognostic value of cytogenetics in adult patients with Philadelphia-negative acute lymphoblastic leukemia.

Gómez-Seguí I, Cervera J, Such E, Martínez-Cuadrón D, Luna I, Ibáñez M, López-Pavía M, Gascón A, Roig M, Martínez J, Sanz J, Montesinos P, Martín-Aragonés G, Lorenzo I, Senent L, Barragán E, Cordón L, Sempere A, Sanz GF, Sanz MA.

Ann Hematol. 2012 Jan;91(1):19-25. doi: 10.1007/s00277-011-1331-z. Epub 2011 Sep 21.

PMID:
21935650
50.

Small nuclear ribonucleoprotein polypeptide N quantitative methylation analysis in infants with central hypotonia.

Nájera N, González L, Pérez Durand J, Ruíz E, Garibay N, Pastrana Y, Barragan E, Durán-R RE, Queipo G.

J Pediatr Endocrinol Metab. 2011;24(7-8):595-8.

PMID:
21932609

Supplemental Content

Loading ...
Support Center